Trials & R&D · first seen 2h ago, updated 2h ago
To get drugmakers into ultra-rare disease, the answer isn’t rare disease at all
OXFORD, England — Making rare disease treatments economically attractive for drugmakers requires looking outside rare disease, according to experts interviewed by Endpoints News. The pharmaceutical industry’s lack of investment in ultra-rar…
Summary from Endpoints News.